<DOC>
	<DOCNO>NCT01836276</DOCNO>
	<brief_summary>The purpose study describe difference quit smoke African Americans ( AA ) White smoker treat varenicline .</brief_summary>
	<brief_title>Understanding Disparities Quitting African American White Smokers</brief_title>
	<detailed_description>While many study evaluate use drug quit smoking among Whites , assess efficacy AAs . Racial/ethical difference smoke well document . AAs smoke less White smoker experience disproportionately great smoke disease death . Past study researcher study look effective smoking cessation method AAs . These method include nicotine gum , nicotine patch buproprion SR . This study evaluate varenicline AA White smoker . There study conduct yet prospectively research AA-White difference smoke cessation also examine potential causal pathway explain AA-White difference quit .</detailed_description>
	<mesh_term>Varenicline</mesh_term>
	<criteria>NonHispanic African American nonHispanic White â‰¥ 18 year age Smoked 320 cigarette per day Smoked &gt; 25 day past 30 day Functioning telephone Interested quit smoking Interested take 3 month varenicline Willing complete study visit Renal impairment Evidence history clinically significant allergic reaction varenicline A cardiovascular event past month Hospitalization past 2 month cardiovascular disease , include limited : Angina Myocardial infarction Peripheral vascular disease Stroke New onset chest pain arrhythmia past 2 month History alcohol drug dependency past year Major depressive disorder last year require treatment History panic disorder , psychosis , bipolar disorder , eat disorder Use tobacco product cigarettes past 30 day Use pharmacotherapy month prior enrollment , include prior use varenicline Pregnant , contemplate get pregnant , breastfeed Plans move KC treatment followup phase Another household member enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>